pharmaphorum

FEBRUARY 25, 2021

Beyond the framework we are also currently developing proposals for an innovative medicines fund,” said Lord Bethell, describing it as an extension of the Cancer Drugs Fund. “It On genomics, he added, the country is going “further and faster”, and ensuring synergy between the Rare Disease Framework and the UK Genomic Healthcare Strategy. “We

Genome 111

Genome Genomics Genetics Medicine 111

The Pharma Data

MARCH 1, 2022

to build a scalable data, analytics, and infrastructure platform This collaboration aims at capturing translational disease insights from large external healthcare biobanks and maximizing value of data for drug discovery and precision medicine. Boehringer Ingelheim partners with Lifebit Biotech, Ltd. More information at www.lifebit.ai.

Biobanking 52

Biobanking Genome Genomics Genome Project 52

pharmaphorum

MARCH 25, 2021

The COSMIC (Catalogue of Somatic Mutations in Cancer) database, operated by the Wellcome Sanger Institute, grew out of the work of the Cancer Genome Project and has been gathering data on mutations associated with specific cancers for almost 17 years.

Drugs 59

Drugs Genome Project Genome Genomics 59

pharmaphorum

FEBRUARY 26, 2021

The field of medicine is riddled with challenges pertaining to diagnosis and finding treatment therapies for rare diseases. Small sample size in trials: Finding eligible patients for clinical trials of orphan medicines is a big challenge. Challenges in rare disease diagnosis and therapy.

Drugs 78

Drugs Genome Project Genome Genomics 78

The Pharma Data

APRIL 6, 2021

and European Union (EU) approvals, will also be presented, including long-term outcomes in patients with TRK fusion cancer receiving larotrectinib and data from the 100,000 Genomes Project analyzing the prognostic factor for survival for patients with tumors that harbor a neurotrophic receptor tyrosine kinase ( NTRK ) gene fusion.

Research 52

Research Genome Project Gene Genome 52

Roots Analysis

AUGUST 31, 2023

Recent advances in DNA sequencing technologies have led to significant developments in healthcare-focused research on precision medicine and diagnostics. Nutrigenomics is the science studying the relationship between human genome, nutrition and health.

Genome 40

Genome Genomics Genetics Gene 40

pharmaphorum

JANUARY 26, 2023

A 2022 study from the Royal College of Physicians and British Pharmacological Society demonstrated the potential of pharmacogenomics, with scientists identifying the genetic cause behind an individual’s drug response for over forty medicines.

Genome 129

Genome Genomics Genome Project Genetics 129

pharmaphorum

DECEMBER 6, 2022

A few decades ago, gathering genetic data on the scale of the 100,000 Genomes Project would have been unthinkable – it was only in 2003 that the entire human genome was mapped. This is the way in which the UK’s Our Future Health research programme aims to provide a breakthrough in healthcare and medicine.

Genome Project 98

Genome Project Research Genome Genomics 98

pharmaphorum

SEPTEMBER 9, 2020

Everything the 100,000 Genomes Project does has to be rubber-stamped by the patients”. It seemed the perfect fit to help me get closer to patients and learn about how precision medicine is evolving.”. Charlie is a member of the UK 100,000 GP study’s dedicated Participant Panel, formed to hold the project to account.

Genome 102

Genome Genomics Genetics Genome Project 102

pharmaphorum

SEPTEMBER 9, 2020

Everything the 100,000 Genomes Project does has to be rubber-stamped by the patients”. It seemed the perfect fit to help me get closer to patients and learn about how precision medicine is evolving.”. Charlie is a member of the UK 100,000 GP study’s dedicated Participant Panel, formed to hold the project to account.

Genome 80

Genome Genomics Genetics Genome Project 80

pharmaphorum

SEPTEMBER 13, 2022

Although early accounts of an illness akin to leukaemia can be traced back to Ancient Greece, the first official description of blood cancer didn’t appear until 1832, when British pathologist and pioneer of preventative medicine Thomas Hodgkin used the controversial concept of micrology to identify the abnormalities in the lymphatic system.

Genome Project 98

Genome Project Genome Genomics DNA 98

Pharmaceutical Technology

JUNE 30, 2022

The group analysed 12,222 samples collected through whole genome sequencing efforts of the UK National Health Service as part of the 100,000 Genomes Project and added further data on 6,418 cancers from the International Cancer Genome Consortium and the Hartwig Medical Foundation. Both teams had the same underlying goal.

Genome Project 130

Genome Project Genome Genomics DNA 130

The Pharma Data

AUGUST 24, 2020

. “This is a very rare example of reinfection,” said Brendan Wren, professor of microbial pathogenesis, at London School of Hygiene and Tropical Medicine. “And it should not negate the global drive to develop Covid-19 vaccines. “It is to be expected that the virus will naturally mutate over time.”

Immune Response 52

Immune Response Genome Project Genome Genomics 52

Pharmaceutical Technology

AUGUST 26, 2008

As understanding of biological systems has forged ahead, pharmaceutical companies have made increasing use of biotechnology in discovering and manufacturing new medicines. It was once derided as the stuff of science fiction, but in recent years, biotechnology has emerged as an important growth area in pharmaceuticals.

Antibody 100

Antibody Licensing Licensing Production 100

XTalks

FEBRUARY 11, 2021

The Human Genome Project recently marked 20 years since the publication of the first full sets of human genomic sequences, an endeavor that spanned well over a decade. Today, new next-generation sequencing technologies allow for the sequencing of complex genomes within just a day or two.

Genetics 119

Genetics DNA Genome Genomics 119